Exploring MDE. To explore a different substance…

Names:
MDE · EVE · MDEA · N-Ethyl-MDA · EA-1304 · N-Ethyl-3,4-methylenedioxyamphetamine · 3,4-Methylenedioxy-N-ethylamphetamine
IUPAC names:
1-(2H-1,3-Benzodioxol-5-yl)-N-ethylpropan-2-amine
1-(1,3-Benzodioxol-5-yl)-N-ethylpropan-2-amine
ID: 106 · Formula: C12H17NO2 · Molecular weight: 207.269
InChI: InChI=1S/C12H17NO2/c1-3-13-9(2)6-10-4-5-11-12(7-10)15-8-14-11/h4-5,7,9,13H,3,6,8H2,1-2H3

Passie, T; Benzenhöfer, U. MDA, MDMA and other mescaline-like substances in the US military’s search for a truth drug (1940s to 1960s). Drug Test. Analysis, 31 Aug 2017, n/a-n/a. 840 kB. http://dx.doi.org/10.1002/dta.2292

Benzenhõfer, U; Passie, T. Rediscovering MDMA (ecstasy): the role of the American chemist Alexander T. Shulgin. Addiction, 1 Aug 2010, 105 (8), 1355–1361. 794 kB. http://dx.doi.org/10.1111/j.1360-0443.2010.02948.x

Freudenmann, RW; Spitzer, M. Neuropsychopharmacology and toxicology of 3,4-methylenedioxy-N-ethyl-amphetamine (MDEA). CNS Drug Rev., 1 Jun 2004, 10 (2), 89–216. 187 kB. http://dx.doi.org/10.1111/j.1527-3458.2004.tb00007.x

Dal Cason, TA. An evaluation of the potential for clandestine manufacture of 3,4-methylenedioxyamphetamine (MDA) analogs and homologs. J. Forensic Sci., 1 May 1990, 35 (3), 675–697. 2.2 MB. http://dx.doi.org/10.1520/JFS12874J

Braun, U; Shulgin, AT; Braun, G. Prüfung auf zentrale Aktivität und Analgesia von N-substituierten Analogen des Amphetamin-Derivates 3,4-Methylendioxyphenylisopropylamin. Arzneim. Forsch., 1 Jan 1980, 30 (5), 825–830. 1.5 MB.

Gouzoulis-Mayfrank, E; Hermle, L. Are the “entactogens” a distinct psychoactive substance class? In Heffter Review; Nichols, DE, Ed., Heffter Research Institute, Santa Fe, NM, 1998; Vol. 1, pp 46–51. 44 kB.

Gouzoulis-Mayfrank, E. Differential actions of an entactogen compared to a stimulant and a hallucinogen in healthy humans. In Heffter Review; Nichols, DE, Ed., Heffter Research Institute, Santa Fe, NM, 2001; Vol. 2, pp 64–72. 261 kB.

Shulgin, AT. Making MDA, MDEA, MDMA. Ask Dr. Shulgin Online, Center for Cognitive Liberty & Ethics, 15 Mar 2001.

Noggle, FT; DeRuiter, J; Coker, ST; Clark, CR. Synthesis, identification, and acute toxicity of some N-alkyl derivatives of 3,4-methylenedioxyamphetamine. J. Assoc. Off. Anal. Chem., 1987, 70 (6), 981–986. 1.8 MB.

Krawczeniuk, AS. Identification of phenethylamines and methylenedioxyamphetamines using liquid chromatography atmospheric pressure electrospray ionization mass spectrometry. Microgram J., 1 Jan 2005, 3 (1–2), 78–100. 979 kB.

Maurer, HH; Kraemer, T; Springer, D; Staack, RF. Chemistry, pharmacology, toxicology, and hepatic metabolism of designer drugs of the amphetamine (Ecstasy), piperazine, and pyrrolidinophenone types. A synopsis. Ther. Drug Monit., 1 Apr 2004, 26 (2), 127–131. 121 kB.

Thigpen, AL; Awad, T; DeRuiter, J; Clark, CR. GC-MS studies on the regioisomeric methoxy-methyl-phenethylamines related to MDEA, MDMMA, and MBDB. J. Chromatogr. Sci., 1 Nov 2008, 46 (10), 900–206. 448 kB. http://dx.doi.org/10.1093/chromsci/46.10.900

Thigpen, AL; DeRuiter, J; Clark, CR. GC-MS studies on the regioisomeric 2,3- and 3,4-methylenedioxyphenethylamines related to MDEA, MDMMA, and MBDB. J. Chromatogr. Sci., 1 May 2007, 45 (5), 229–235. 332 kB. http://dx.doi.org/10.1093/chromsci/45.5.229

Schmidt, WJ; Mayerhofer, A; Meyer, A; Kovar, K. Ecstasy counteracts catalepsy in rats, an anti-parkinsonian effect? Neurosci. Lett., 27 Sep 2002, 330 (3), 251–254. 280 kB. http://dx.doi.org/10.1016/S0304-3940(02)00823-6

Trachsel, D. Fluorine in psychedelic phenethylamines. Drug Test. Analysis, 1 Jul 2012, 4 (7-8), 577-590. 1.0 MB. http://dx.doi.org/10.1002/dta.413

Braun, U; Shulgin, AT; Braun, G. Centrally active N-substituted analogs of 3,4-methylenedioxyphenylisopropylamine (3,4-methylenedioxyamphetamine). J. Pharm. Sci., 1 Jan 1980, 69 (2), 192–195. 513 kB. http://dx.doi.org/10.1002/jps.2600690220

Shulgin, AT. Psychotomimetic drugs: structure-activity relationships. In Handbook of Psychopharmacology: Stimulants; Iversen, LL; Iversen, SD; Snyder, SH, Eds., Plenum Press, New York, 1978; Vol. 11, pp 243–333. 2.6 MB. http://dx.doi.org/10.1007/978-1-4757-0510-2_6 Rhodium.

Nieddu, M; Burrai, L; Pirisi, MA; Carta, A; Briguglio, I; Dessi, G; Boatto, G. Validated liquid chromatography-mass spectrometry method for the quantitation of N-substituted derivatives of 3,4-methylenedioxyamphetamine in rat urine. Forensic Toxicol., 1 Jul 2013, 31 (2), 204–211. 527 kB. http://dx.doi.org/10.1007/s11419-013-0178-5

Hermle, L; Fünfgeld, M; Oepen, G; Botsch, H; Borchardt, D; Gouzoulis, E; Fehrenbach, RA; Spitzer, M. Mescaline-induced psychopathological, neuropsychological, and neurometabolic effects in normal subjects: Experimental psychosis as a tool for psychiatric research. Biol. Psychiat., 1 Dec 1992, 32 (11), 976–991. 1.6 MB. http://dx.doi.org/10.1016/0006-3223(92)90059-9

Stone, DM; Johnson, M; Hanson, GR; Gibb, JW. A comparison of the neurotoxic potential of methylenedioxyamphetamine (MDA) and its N-methylated and N-ethylated derivatives. Eur. J. Pharmacol., 10 Feb 1987, 134 (2), 245–248. 316 kB. http://dx.doi.org/10.1016/0014-2999(87)90173-7

Al-Hossaini, AM. GC-MS and GC-IRD studies on ethoxyphenethylamines related to MDEA, MDMMA and MBDB. Ph. D. Thesis, Auburn University, Auburn, AL, USA, 18 Dec 2009. 1.2 MB.

Nakanishi, K; Miki, A; Zaitsu, K; Kamata, H; Shima, N; Kamata, T; Katagi, M; Tatsuno, M; Tsuchihashi, H; Suzuki, K. Cross-reactivities of various phenethylamine-type designer drugs to immunoassays for amphetamines, with special attention to the evaluation of the one-step urine drug test Instant-View™, and the Emit® assays for use in drug enforcement. Forensic Sci. Int., 10 Apr 2012, 217 (1–3), 174–181. 397 kB. http://dx.doi.org/10.1016/j.forsciint.2011.11.003

Nash, JF; Nichols, DE. Microdialysis studies on 3,4-methylenedioxyamphetamine and structurally related analogues. Eur. J. Pharmacol., 1 Jan 1991, 200 (1), 53–58. 714 kB. http://dx.doi.org/10.1016/0014-2999(91)90664-C

Świst, M; Wilamowski, J; Zuba, D; Kochana, J; Parczewski, A. Determination of synthesis route of 1-(3,4-methylenedioxyphenyl)-2-propanone (MDP-2-P) based on impurity profiles of MDMA. Forensic Sci. Int., 10 May 2005, 149 (2–3), 181–192. 594 kB. http://dx.doi.org/10.1016/j.forsciint.2004.06.016

Glennon, RA; Yousif, M; Patrick, G. Stimulus properties of 1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDA) analogs. Pharmacol. Biochem. Behav., 1 Mar 1988, 29 (3), 443–449. 551 kB. http://dx.doi.org/10.1016/0091-3057(88)90001-9

McKenna, DJ; Guan, AM; Shulgin, AT. 3,4-Methylenedioxyamphetamine (MDA) analogues exhibit differential effects on synaptosomal release of 3H-dopamine and 3H-5-hydroxytryptamine. Pharmacol. Biochem. Behav., 1 Jan 1991, 38 (3), 505–12. 783 kB. http://dx.doi.org/10.1016/0091-3057(91)90005-M

FLEA
MDA
MDAL
MDBU
MDBZ
MDCPM
MDDM
MDHOET
MDIP
MDMA
MDMEO
MDMEOET
MDOH
MDPL
MDPR
MDIB
MDTB
MDAM
MDHE
MDOC
MDDEA · MDDE
MDCM
MDBA
MDTFEA
MDMEA
MDMPA
MDMIPA
MDSB
N-Formyl-MDMA
EBDB · ETHYL-J
ETHYL-K
ETHYL-L
N-Et-MDPEA
F2-MDE
DHEA
6622
EDEA
6-EAPB
5-EAPB
6-EAPDB
5-EAPDB
homo-MDPEA · GAMMA
Safrole
α-Isosafrole
β-Isosafrole
ONE · MDC
MDPPP
5,6-MDAI
EtONE · Ethylone
6,7-MDAT
α-Me-N-Et-MDBA
α-MMDBA
MDBZP · Methylenedioxybenzylpiperazine
homo-MDA
homo-MDE
MDCPA
499
MDAR
2563
2566
MDEAR
DMCPA
MADAM-6
MDDM
MDMC
MDMP
METHYL-J
F
IDA
K
2C-G-2
MADAM-2
2C-VI
DOMAI · DOM-AI
4-MeO-3-Me-MCAT
5,8-ADT
MeO-B · 4-Methoxybuphedrone
DMA-2-hemiFLY
4-Propoxycathinone
α-Me-N-Pr-MDBA
α,α,N,N-TMMDBA
homo-MDMA
α-Me-N-iPr-MDBA
BO3A
Hordenine acetate
2,3-MDDMA
2,3-MDE
2,3-MBDB
MAPEA
N-Me-N-Et-MDPEA
N-Pr-MDPEA
N-iPr-MDPEA
α-Et-MDA
α-iPr-MDPEA
ED-N-DMPEA
2,5-DMA-hemiFly-5 · SF
G-1
M-7
N-Et-ADTN
1095
1084
1006
FLEA
MDA
MDAL
MDBU
MDBZ
MDCPM
MDDM
MDHOET
MDIP
MDMA
MDMEO
MDMEOET
MDOH
MDPL
MDPR
MDIB
MDTB
MDAM
MDHE
MDOC
MDDEA · MDDE
MDCM
MDBA
MDTFEA
MDMEA
MDMPA
MDMIPA
MDSB
N-Formyl-MDMA
EBDB · ETHYL-J
ETHYL-K
ETHYL-L
N-Et-MDPEA
F2-MDE
DHEA
6622
EDEA
6-EAPB
5-EAPB
6-EAPDB
5-EAPDB
homo-MDPEA · GAMMA
Safrole
α-Isosafrole
β-Isosafrole
ONE · MDC
MDPPP
5,6-MDAI
EtONE · Ethylone
6,7-MDAT
α-Me-N-Et-MDBA
α-MMDBA
MDBZP · Methylenedioxybenzylpiperazine
homo-MDA
homo-MDE
MDCPA
499
MDAR
2563
2566
MDEAR
DMCPA
MADAM-6
MDDM
MDMC
MDMP
METHYL-J
F
IDA
K
2C-G-2
MADAM-2
2C-VI
DOMAI · DOM-AI
4-MeO-3-Me-MCAT
5,8-ADT
MeO-B · 4-Methoxybuphedrone
DMA-2-hemiFLY
4-Propoxycathinone
α-Me-N-Pr-MDBA
α,α,N,N-TMMDBA
homo-MDMA
α-Me-N-iPr-MDBA
BO3A
Hordenine acetate
2,3-MDDMA
2,3-MDE
2,3-MBDB
MAPEA
N-Me-N-Et-MDPEA
N-Pr-MDPEA
N-iPr-MDPEA
α-Et-MDA
α-iPr-MDPEA
ED-N-DMPEA
2,5-DMA-hemiFly-5 · SF
G-1
M-7
N-Et-ADTN
1095
1084
1006
20 November 2017 · Creative Commons BY-NC-SA ·